Comments
Netherlands based RegPak Bio-pharma today announced a tie up with a Taiwan based company Meriyana International Biotechnology to sell Chinese herbal medicine for cancer treatment in India through its Indian subsidiary Cancure (P) Ltd based here.
Announcing this, Parminder Kaur, CEO of RegPak BioPharma said: “Doctors have been shortlisted to undergo training in Taiwan to work in the CanCure Clinics to be set up in Chandigarh and later, various parts of Punjab”.
She said a substantial number of patients suffer from cancer in various areas of Punjab and claimed that the Chinese medicine would be helpful in treating those patients effectively.
Accompanied by the representatives of Meriyana International, Parminder Kaur said the herbal medicine, ’Chinmanna’, has undergone several clinical trials in Taiwan, and that RegPak would be introducing it very soon in Europe where it has got the approvals to be introduced as compassionate medicine for terminal cancer patients.
Chinmanna is launched for treatment of various types of cancers including breast, stomach, throat, mouth, pancreas, intestinal and spleen cancer, she claimed.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.